Software / Technology Platform · +4 more types
Products: GastroPlus, MonolixSuite +9 more
“Using population-based pharmacokinetic models, we can characterize drug disposition using sparse drug concentration data in patients with the condition of interest, whereas…”Source: simulations-plus.com
Also offers: Model-Informed Drug Development (MIDD), PBPK Modeling, +2 more
CRO / Research Services Provider · +2 more types
Products: ClinQuick
“…Study design input, PK and PD analysis and consultation, and written interpretation of PK and PD results for ICH study reports round out our comprehensive service offering…”Source: celerion.com
Also offers: First-in-Human (Phase I) Clinical Pharmacology Support, Clinical Trial Bioanalytical & Biomarker Testing, +2 more
Service Provider · +2 more types
Products: D.AI.M.I.
“Non-compartmental analysis (NCA) and population PK/PD modeling”Source: plglifesciences.com
Also offers: Regulatory Development Strategy & Agency Interactions, End-to-End Pharmacovigilance Outsourcing, +6 more
CRO / Research Services Provider · +7 more types
Products: IQVIA Vigilance Platform, SmartSolve +4 more
“Each carefully-selected site brings expertise in regulatory pathways, accelerated titration and BOIN designs, PK/PD modeling, receptor occupancy, immunologic pathways, and a full…”Source: iqvia.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Real-World Data Platform, +6 more
CRO / Research Services Provider · +5 more types
“Pharmacokinetic and pharmacodynamic data analysis and modeling”Source: frontagelab.com
Also offers: Bioanalysis & Biomarker Assay Services, Integrated CDMO/CMO Services, +3 more
CRO / Research Services Provider · +5 more types
Products: Teklad, Target Sufficiency +1 more
“The team supports PK/ PD sample analysis, drug–drug interaction studies, concomitant drug analysis, and bioequivalence programs.”Source: inotiv.com
Also offers: Toxicology Studies, In Vivo Pharmacology & Efficacy Models, +3 more
CRO / Research Services Provider · +3 more types
Products: Acceleration Platform
“We have extensive experience in study design and PK/PD analysis of novel biologics and biosimilars in preclinical and clinical settings.”Source: altasciences.com
Also offers: Toxicology Studies, First-in-Human (Phase I) Clinical Pharmacology Support, +2 more